Urate Lowering and Cardiovascular Risk—Extending the Benefits of a Treat-to-Target Strategy in Gout

Corresponding Author: Pascal Richette MD, PhD, Service de Rhumatologie, Hôpital Lariboisière, Université Paris Cité, 2 Rue Ambroise Paré, 750 10 Paris, France (pascal.richette@aphp.fr).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.